Literature DB >> 21430655

Role of innate cytokines in mycobacterial infection.

A M Cooper1, K D Mayer-Barber, A Sher.   

Abstract

Cells of the innate immune system produce cytokines and lipid mediators that strongly influence the outcome of mycobacterial infection. In the case of Mycobacterium tuberculosis, the lung is a critical site for this interaction. Here, we review current information on the role of the major innate cytokine pathways both in controlling initial infection as well as in promoting and maintaining adaptive T-cell responses that mediate host resistance or immunopathology. Understanding this important feature of the host-pathogen interaction can provide major insights into the mechanisms of virulence and can lead to new approaches for immunological intervention in tuberculosis and other mycobacterial diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21430655      PMCID: PMC3294290          DOI: 10.1038/mi.2011.13

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  101 in total

1.  Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis.

Authors:  L M Gomez; J F Camargo; J Castiblanco; E A Ruiz-Narváez; J Cadena; J M Anaya
Journal:  Tissue Antigens       Date:  2006-04

Review 2.  Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features.

Authors:  Orchidée Filipe-Santos; Jacinta Bustamante; Ariane Chapgier; Guillaume Vogt; Ludovic de Beaucoudrey; Jacqueline Feinberg; Emmanuelle Jouanguy; Stéphanie Boisson-Dupuis; Claire Fieschi; Capucine Picard; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2006-09-25       Impact factor: 11.130

3.  IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection.

Authors:  Euan Lockhart; Angela M Green; JoAnne L Flynn
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

4.  Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system.

Authors:  Jason S Stumhofer; Arian Laurence; Emma H Wilson; Elaine Huang; Cristina M Tato; Leanne M Johnson; Alejandro V Villarino; Qiulong Huang; Akihiko Yoshimura; David Sehy; Christiaan J M Saris; John J O'Shea; Lothar Hennighausen; Matthias Ernst; Christopher A Hunter
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

5.  Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence.

Authors:  Vivek Rao; Feng Gao; Bing Chen; William R Jacobs; Michael S Glickman
Journal:  J Clin Invest       Date:  2006-06       Impact factor: 14.808

6.  Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway.

Authors:  Claudia Manca; Liana Tsenova; Sherry Freeman; Amy K Barczak; Michael Tovey; Peter J Murray; Clifton Barry; Gilla Kaplan
Journal:  J Interferon Cytokine Res       Date:  2005-11       Impact factor: 2.607

7.  NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis.

Authors:  Carl G Feng; Mallika Kaviratne; Antonio Gigliotti Rothfuchs; Allen Cheever; Sara Hieny; Howard A Young; Thomas A Wynn; Alan Sher
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

8.  Variable host-pathogen compatibility in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux; Kathryn DeRiemer; Tran Van; Midori Kato-Maeda; Bouke C de Jong; Sujatha Narayanan; Mark Nicol; Stefan Niemann; Kristin Kremer; M Cristina Gutierrez; Markus Hilty; Philip C Hopewell; Peter M Small
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

9.  Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection.

Authors:  Shabaana A Khader; Santiago Partida-Sanchez; Guy Bell; Dawn M Jelley-Gibbs; Susan Swain; John E Pearl; Nico Ghilardi; Frederic J Desauvage; Frances E Lund; Andrea M Cooper
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

10.  TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.

Authors:  Andre Bafica; Charles A Scanga; Carl G Feng; Cynthia Leifer; Allen Cheever; Alan Sher
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

View more
  107 in total

1.  Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection.

Authors:  Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; JoAnne L Flynn; Denise E Kirschner
Journal:  Infect Immun       Date:  2014-11-03       Impact factor: 3.441

2.  Influence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology.

Authors:  Kerry J Welsh; Shen-An Hwang; Sydney Boyd; Marian L Kruzel; Robert L Hunter; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2011-12-03       Impact factor: 3.131

Review 3.  The roles of microRNAs on tuberculosis infection: meaning or myth?

Authors:  Harapan Harapan; Fitra Fitra; Ichsan Ichsan; Mulyadi Mulyadi; Paolo Miotto; Nabeeh A Hasan; Marta Calado; Daniela M Cirillo
Journal:  Tuberculosis (Edinb)       Date:  2013-08-15       Impact factor: 3.131

4.  Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression.

Authors:  Antonia Fettelschoss; Magdalena Kistowska; Salomé LeibundGut-Landmann; Hans-Dietmar Beer; Pål Johansen; Gabriela Senti; Emmanuel Contassot; Martin F Bachmann; Lars E French; Annette Oxenius; Thomas M Kündig
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

5.  Colonization with Helicobacter is concomitant with modified gut microbiota and drastic failure of the immune control of Mycobacterium tuberculosis.

Authors:  L Majlessi; F Sayes; J-F Bureau; A Pawlik; V Michel; G Jouvion; M Huerre; M Severgnini; C Consolandi; C Peano; R Brosch; E Touati; C Leclerc
Journal:  Mucosal Immunol       Date:  2017-02-01       Impact factor: 7.313

Review 6.  Heterogeneity in tuberculosis.

Authors:  Anthony M Cadena; Sarah M Fortune; JoAnne L Flynn
Journal:  Nat Rev Immunol       Date:  2017-07-24       Impact factor: 53.106

Review 7.  Killing Mycobacterium tuberculosis In Vitro: What Model Systems Can Teach Us.

Authors:  Tracy L Keiser; Georgiana E Purdy
Journal:  Microbiol Spectr       Date:  2017-06

Review 8.  Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.

Authors:  Katrin D Mayer-Barber; Daniel L Barber
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-17       Impact factor: 6.915

9.  A hydrolase of trehalose dimycolate induces nutrient influx and stress sensitivity to balance intracellular growth of Mycobacterium tuberculosis.

Authors:  Yong Yang; Kathleen Kulka; Ronald C Montelaro; Todd A Reinhart; James Sissons; Alan Aderem; Anil K Ojha
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

10.  Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection.

Authors:  R C Chukwuanukwu; C C Onyenekwe; L Martinez-Pomares; R Flynn; S Singh; G I Amilo; N R Agbakoba; J O Okoye
Journal:  Clin Exp Immunol       Date:  2016-10-21       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.